5-Amino-1MQ dose guide

5-Amino-1MQ dosage

A small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, which raises NAD+ and pushes fat cells toward burning energy. In obese mice it reduced weight and fat without cutting food intake. Commonly reported: nothing to feel, though some describe easier fat loss alongside a deficit or a GLP-1. There are no human studies, and the mouse work used injections rather than oral doses.

Dose range

50–100 mg (research range). Studied in research — not a recommendation.

How often

Daily

A typical run

Very limited data. Some run 8–12 weeks then cycle off. Preclinical compound — approach conservatively.

How it’s taken

Taken by mouth: Oral

Evidence

Emerging: Primarily preclinical / limited human data

Half-life

Unknown

5-Amino-1MQ on your syringe

Taken by mouth, so there’s nothing to draw.

5-Amino-1MQ in the peptide libraryThe Dose Guide: every peptide

More glp-1 & metabolic peptides

• Semaglutide 0.25–2.4 mg
• Semaglutide (oral) 1.5–25 mg
• Tirzepatide 2.5–15 mg
• Retatrutide 1–12 mg
• Liraglutide 0.6–3 mg
• Dulaglutide 0.75–4.5 mg
• Orforglipron 0.8–17.2 mg
• Survodutide 0.3–6 mg
• Mazdutide 2–6 mg
• Pemvidutide 1.2–2.4 mg
• Cagrilintide 0.25–2.4 mg
• CagriSema 0.25–2.4 mg
• SLU-PP-332 250–1000 mcg
• Oxytocin 10–40 IU

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.